Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
Top brokers name 3 ASX shares to buy today
Why Calix, Chrysos, Inghams, and Life360 shares are pushing higher today
Why is this ASX 300 share plunging 13% after landing a deal?
Why Australian Strategic Materials, Calix, Sayona Mining, and Tietto shares are rising
This ASX battery materials technology share can double in value: broker
Why Calix, Codan, PSC, and Symbio shares are rising today
Pilbara Minerals share price lower despite mid-stream 'game changer'
Energy transition is irresistible. Expert tips the ASX share to cash in
Pilbara Minerals share price higher on mid-stream demo plant update
'Compelling' decarbonisation ASX share to buy for dirt cheap right now
'Key pick': 2 ASX energy shares that you need to jump on now
Top brokers name 3 ASX shares to buy today
Calix Ltd does not pay shareholder dividends at this time.
Calix listed on the ASX on 20 July 2018.
|26 Sep 2005||$0.0150||100.00%||Final||07 Oct 2005|
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Calix Ltd (ASX: CXL) is an Australian technology company. It has developed a patented, platform technology that essentially involves grinding minerals to between one-hundredth and one-thousandth of a millimetre in size, and then "flash" heating them in a reactor. As trapped gases in the minerals are released, they create highly porous honeycomb-like structures with similar properties to nanomaterials, but without the associated safety issues and costs. Calix's technology also allows for the separation of carbon dioxide, making it attractive to industries and companies looking to reduce carbon emissions.
Calix's technology is being used globally across many industries and sectors. These include advanced battery development, water and wastewater treatment, sustainable food, and biotechnology. The company has operations in Australia, New Zealand, Asia, Europe, and the United States.
|08 Dec 2023||$3.57||$-0.08||-2.19%||91,108||$3.52||$3.67||$3.40|
|07 Dec 2023||$3.65||$0.10||2.82%||303,448||$3.50||$3.69||$3.50|
|06 Dec 2023||$3.55||$0.06||1.72%||223,522||$3.45||$3.60||$3.39|
|05 Dec 2023||$3.49||$-0.05||-1.41%||149,684||$3.50||$3.52||$3.36|
|04 Dec 2023||$3.54||$0.07||2.02%||231,409||$3.50||$3.59||$3.50|
|01 Dec 2023||$3.47||$-0.11||-3.07%||231,588||$3.60||$3.60||$3.47|
|30 Nov 2023||$3.58||$0.13||3.77%||656,838||$3.46||$3.59||$3.36|
|29 Nov 2023||$3.45||$0.08||2.37%||53,469||$3.37||$3.45||$3.33|
|28 Nov 2023||$3.37||$0.06||1.81%||72,142||$3.35||$3.40||$3.32|
|27 Nov 2023||$3.31||$-0.06||-1.78%||108,263||$3.33||$3.37||$3.30|
|24 Nov 2023||$3.37||$0.04||1.20%||117,143||$3.33||$3.46||$3.33|
|23 Nov 2023||$3.33||$0.03||0.91%||213,914||$3.30||$3.37||$3.28|
|22 Nov 2023||$3.30||$-0.15||-4.35%||125,662||$3.42||$3.42||$3.28|
|21 Nov 2023||$3.45||$0.03||0.88%||209,823||$3.40||$3.48||$3.34|
|20 Nov 2023||$3.42||$-0.05||-1.44%||247,463||$3.44||$3.48||$3.28|
|17 Nov 2023||$3.47||$-0.07||-1.98%||270,651||$3.59||$3.59||$3.42|
|16 Nov 2023||$3.54||$0.00||0.00%||336,565||$3.50||$3.60||$3.46|
|15 Nov 2023||$3.54||$0.37||11.67%||281,371||$3.25||$3.54||$3.25|
|14 Nov 2023||$3.17||$0.02||0.63%||364,881||$3.10||$3.21||$3.09|
|13 Nov 2023||$3.15||$0.01||0.32%||101,456||$3.23||$3.25||$3.10|
|24 Aug 2023||Mark Sceats||Buy||100,000||$439,000||
Off-market trade. As per announcement on 29-08-2023
|Ms Catriona Alison Deans||Non-Executive Director||Mar 2023||
Ms Deans is also a member of the Investment Committee at Main Sequence Ventures (CSIRO's innovation fund) and a Member of the AICD Corporate Governance Committee. Alison's previous directorships include Westpac Banking Corporation, Insurance Australia Group Limited and Social Ventures Australia. In her executive career, Alison was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas, CEO of netus Pty Ltd (a technology investment company acquired by Fairfax), and a consultant with McKinsey & Company. She is member of Risk Management Committee and the Sustainability Committee.
|Mr Peter John Turnbull||Non-Executive ChairmanNon-Executive Director||Feb 2009||
Mr Turnbull is a chair and professional non-executive director of publicly listed unlisted and technology companies in the scale up phase. Sector experience spans technology commercialization, artificial intelligence, oil and gas, mining, and industrial manufacturing. Peter has over 25 years successful senior executive and corporate legal experience with some of Australia's listed and unlisted public companies, including Newcrest Mining, BTR Nylex and Energex. Peter also has corporate regulatory and government policy experience gained through working with the Australian Securities and Investments Commission and the Hong Kong Securities & Futures Commission. He is also a member of the Risk Management Committee and Sustainability Committee.
|Ms Helen E Fisher||Non-Executive Director||Sep 2020||
Ms Fisher is Managing Director and CEO of Bio Capital Impact Fund (BCIF). Prior to establishing BCIF, Helen was a partner of Deloitte for over 10 years and led Deloitte's Life Sciences industry practice in Australia for five years, having had many years of experience in the Life Sciences and Health Care industry. She also specialized in Financial Services, servicing some of the Australian banks and funds and has been involved in setting up several international funds, as well as advised on several M&A deals. Helen provided strategic advice to publicly listed multinational companies and has experience with capital raisings, licensing deals, demergers, implementing offshore expansions, IP management and location, and supply chain management. She is Chair of the Risk Management Committee and member of the Sustainability Committee.
|Mr Lance Adrian Wingate O'Neill||Non-Executive Director||Feb 2014||
Lance O'Neill is a Director of DFB (Australia) Pty Ltd, a Sydney based investment advisory business, and has worked in institutional equity, fixed income sales/trading and corporate finance in international securities and investment markets for over thirty years predominantly in Australia, UK and USA. He is the chair of MediaZest Plc and EP&F Capital Plc and in addition is and has been a director of, and investor in, a number of private and public companies in Australia, UK, and the USA.
|Dr Mark Geoffrey Sceats||Chief ScientistExecutive Director||Feb 2014||
Dr Sceats has previously worked at the James Franck Institute at the University of Chicago, and a Research Associate, and as an Assistant Professor of the University of Rochester NY, USA, where he was awarded the Alfred P Sloan Fellowship for his work. Later he was employed by the University of Sydney as a Reader in the School of Chemistry for his research work on chemical reaction kinetics and led the Australian Photonics CRC from 1991-2004. Mark has published more than 165 academic papers in physical chemistry and is an inventor of 55 patented inventions. He is also member of the Technology Committee.
|Dr Philip (Phil) Hargraves Hodgson||Chief Executive OfficerManaging Director||Feb 2014||
Dr Hodgson has a technical and commercial background from a career with Shell, where for over 14 years he developed depth of experience across all sectors of the downstream oil industry, including refining and supply, marketing and sales, pricing strategy, risk management, corporate strategy, and mergers and acquisitions. From 2007 to 2013, Phil ran his own consultancy, providing project development, commercial, M&A, and management expertise to several sectors, including LNG, biofuel, clean coal, geothermal energy, building products, logistics and fast-moving consumer goods. He is also member of Technology Committee.
|Mr Darren Charles||Chief Financial OfficerCompany Secretary||
|Darren Charles||Chief Financial OfficerCompany Secretary||
|Hinne Temminck Tuinstra||GM Strategy & Portfolio||
|Doug Kelley||President of IER||
|J P Morgan Nominees Australia Pty Limited||37,461,133||20.67%|
|HSBC Custody Nominees (Australia) Limited||20,484,349||11.30%|
|UBS Nominees Pty Ltd||10,915,798||6.02%|
|Citicorp Nominees Pty Limited||9,357,470||5.16%|
|Mr Paul Crowther||6,444,063||3.56%|
|BNP Paribas Noms Pty Ltd <DRP>||4,412,881||2.44%|
|Mark Geoffrey Sceats <Sceats Superannuation Fund>||2,847,344||1.57%|
|Dr Mark Geoffrey Sceats||2,632,119||1.45%|
|Pigeons Super Pty Limited <The Hodgson Family S/F A/C>||2,196,597||1.21%|
|National Nominees Limited||2,139,393||1.18%|
|BNP Paribas Nominees Pty Ltd <Agency Lending DRP A/C>||2,096,270||1.16%|
|Ubs Nominees Pty Ltd i||1,773,836||0.98%|
|Mr Jacob Shields Ulrich||1,533,133||0.85%|
|BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C>||1,324,244||0.73%|
|Jeneil Super Pty Ltd <Jeneil Super Fund A/C>||1,266,387||0.70%|
|Mr John Andrew Hamilton||1,223,639||0.68%|
|Turnbull Super Fund Pty Ltd <The Turnbull Super Fund A/C>||1,133,789||0.63%|
|Shareholder Services Pty Ltd||1,098,091||0.61%|